Geri Michelle Mc Shane is VP, Controller & CAO of Xylem Inc.. Currently has a direct ownership of 3,536 shares of XYL, which is worth approximately $414,207. The most recent transaction as insider was on Jun 10, 2024, when has been sold 2,278 shares (Common Stock) at a price of $138.63 per share, resulting in proceeds of $315,799. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.54K
0% 3M change
9.61% 12M change
Total Value Held $414,207

Geri-Michelle McShane Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 10 2024
SELL
Open market or private sale
$315,799 $138.63 p/Share
2,278 Reduced 39.18%
3,536 Common Stock
Jun 10 2024
BUY
Exercise of conversion of derivative security
$131,796 $74.63 p/Share
1,766 Added 23.3%
5,814 Common Stock
Mar 01 2024
SELL
Payment of exercise price or tax liability
$97,106 $127.94 p/Share
759 Reduced 17.86%
3,491 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
$239,503 $127.94 p/Share
1,872 Added 31.62%
4,048 Common Stock
Feb 20 2024
SELL
Open market or private sale
$122,890 $122.89 p/Share
1,000 Reduced 25.41%
2,935 Common Stock
Mar 01 2023
SELL
Payment of exercise price or tax liability
$16,275 $101.09 p/Share
161 Reduced 4.75%
3,226 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
680 Added 14.83%
3,906 Common Stock
Feb 27 2023
SELL
Payment of exercise price or tax liability
$51,069 $102.55 p/Share
498 Reduced 12.82%
3,387 Common Stock
Feb 27 2023
BUY
Grant, award, or other acquisition
-
1,011 Added 20.65%
3,885 Common Stock
Mar 01 2022
SELL
Payment of exercise price or tax liability
$6,247 $86.76 p/Share
72 Reduced 3.26%
2,138 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
720 Added 20.12%
2,858 Common Stock
Feb 27 2022
SELL
Payment of exercise price or tax liability
$7,561 $88.95 p/Share
85 Reduced 3.7%
2,210 Common Stock
Feb 20 2022
SELL
Payment of exercise price or tax liability
$33,484 $90.01 p/Share
372 Reduced 13.95%
2,295 Common Stock
Feb 20 2022
BUY
Grant, award, or other acquisition
-
719 Added 21.23%
2,667 Common Stock
Jun 07 2021
SELL
Open market or private sale
$236,751 $119.33 p/Share
1,984 Reduced 50.81%
1,921 Common Stock
Jun 07 2021
BUY
Exercise of conversion of derivative security
$107,476 $74.07 p/Share
1,451 Added 27.09%
3,905 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
611 Added 19.93%
2,454 Common Stock
Feb 27 2021
SELL
Payment of exercise price or tax liability
$7,156 $102.23 p/Share
70 Reduced 3.66%
1,843 Common Stock
Feb 21 2021
SELL
Payment of exercise price or tax liability
$17,807 $99.48 p/Share
179 Reduced 8.56%
1,913 Common Stock
Feb 21 2021
BUY
Grant, award, or other acquisition
-
373 Added 15.32%
2,061 Common Stock
Feb 20 2021
SELL
Payment of exercise price or tax liability
$6,665 $99.48 p/Share
67 Reduced 3.75%
1,719 Common Stock
GM

Geri Michelle Mc Shane

VP, Controller & CAO
Rye Brook, NY

Track Institutional and Insider Activities on XYL

Follow Xylem Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XYL shares.

Notify only if

Insider Trading

Get notified when an Xylem Inc. insider buys or sells XYL shares.

Notify only if

News

Receive news related to Xylem Inc.

Track Activities on XYL